- Home
- INSG vs TLPH Comparison
INSG vs TLPH Comparison
Compare INSG & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INSG | TLPH |
|---|---|---|
| Founded | 1996 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.9M | 70.3M |
| IPO Year | 2000 | 2010 |
Fundamental Metrics
Financial Performance| Metric | INSG | TLPH |
|---|---|---|
| Price | $4.31 | $1.21 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.33 | N/A |
| AVG Volume (30 Days) | ★ 441.7K | 306.1K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $313,832,000.00 | $2,151,000.00 |
| Revenue This Year | $16.21 | N/A |
| Revenue Next Year | $13.28 | N/A |
| P/E Ratio | $30.92 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.96 | $0.50 |
| 52 Week High | $21.90 | $1.57 |
Technical Indicators
Market Signals| Indicator | INSG | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 24.49 | 44.49 |
| Support Level | N/A | $0.74 |
| Resistance Level | $12.95 | $1.29 |
| Average True Range (ATR) | 0.43 | 0.09 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 5.87 | 25.64 |
Price Performance
Historical ComparisonAbout INSG Inseego Corp.
Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.